🔥 Burn Fat Fast. Discover How! 💪

JPMorgan Chase Monthly Pick Every month, JPMorgan analysts | 🚀 Robin Rocket

JPMorgan Chase Monthly Pick

Every month, JPMorgan analysts publish a list of their top picks from various sectors. The selection consists of both growth stocks and value stocks.

Top ideas for September, according to JPMorgan:

Sunrun $RUN is an American supplier of solar panels and batteries. Analysts expect a significant increase in sales margins in the second half of the year. The company also has large inventories, which will help it avoid supply chain problems.
Target price from JPMorgan - $86, upside potential +87%

Dollar General $DG is an American chain of grocery and household goods stores.
Target price from Raymond James - $260, upside potential +17%

Bath&Body Works $BBWI is a retailer of cosmetics and home decorating products.
Target price from Citigroup - $85, upside potential +30%

FedEx $FDX is a company providing postal, courier and other logistics services around the world.
Target price from Cowen - $335, upside potential +26%

Signature Bank $SBNY is a universal commercial bank.
Target price from Morgan Stanley - $340, upside potential +30%

Constellation Brands $STZ is an international company engaged in the production and sale of beer, wine and spirits.
Target price from Credit Suisse - $275, upside potential +30%

Eli Lilly and Co $LLY is an American pharmaceutical company.
Target price from Cowen - $300, upside potential +16%

Peloton Interactive $PTON is a manufacturer of various exercise equipment.
Target price from JPMorgan - $138, upside potential +40%

Dell Technologies $DELL - the company's shares are already up more than 30% since the beginning of the year. Analysts believe that the growth in demand for products will continue due to the uncertainty surrounding the pandemic.
Target price from JPMorgan - $120, upside potential +24%

State Street $STT is an American depository and investment company.
Target price from Morgan Stanley - $117, upside potential +28%

Not an investment recommendation.